22 Nw, LP Regenxbio Inc. Transaction History
22 Nw, LP
- $143 Million
- Q3 2025
A detailed history of 22 Nw, LP transactions in Regenxbio Inc. stock. As of the latest transaction made, 22 Nw, LP holds 923,679 shares of RGNX stock, worth $10.6 Million. This represents 6.25% of its overall portfolio holdings.
Number of Shares
923,679
Previous 923,679
-0.0%
Holding current value
$10.6 Million
Previous $7.58 Million
17.54%
% of portfolio
6.25%
Previous 6.38%
Shares
2 transactions
Others Institutions Holding RGNX
# of Institutions
189Shares Held
44.7MCall Options Held
138KPut Options Held
117K-
Black Rock Inc. New York, NY8.61MShares$99.1 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.69MShares$54 Million4.99% of portfolio
-
Jpmorgan Chase & CO New York, NY4.04MShares$46.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.34MShares$38.4 Million0.0% of portfolio
-
State Street Corp Boston, MA1.98MShares$22.8 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $498M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...